These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36420072)

  • 1. Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma
    Yabuuchi Y; Hiroshima K; Oshima H; Kanazawa J; Hayashihara K; Nakagawa T; Shimanouchi M; Usui S; Oh-Ishi S; Saito T; Hizawa N; Minami Y
    Oncol Lett; 2022 Dec; 24(6):440. PubMed ID: 36420072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant mesothelioma in situ diagnosed by methylthioadenosine phosphorylase loss and homozygous deletion of CDKN2A: a case report.
    Minami K; Jimbo N; Tanaka Y; Hokka D; Miyamoto Y; Itoh T; Maniwa Y
    Virchows Arch; 2020 Mar; 476(3):469-473. PubMed ID: 31667596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens.
    Berg KB; Churg AM; Cheung S; Dacic S
    Cancer Cytopathol; 2020 Feb; 128(2):126-132. PubMed ID: 31821740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9-month interval with details analysis of cytology in early-stage mesothelioma.
    Yoshida M; Jimbo N; Tsukamoto R; Itoh T; Kawahara K; Mitsui S; Tanaka Y; Maniwa Y
    Diagn Pathol; 2023 Nov; 18(1):126. PubMed ID: 38017544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic mesothelioma biomarkers in effusion cytology.
    Eccher A; Girolami I; Lucenteforte E; Troncone G; Scarpa A; Pantanowitz L
    Cancer Cytopathol; 2021 Jul; 129(7):506-516. PubMed ID: 33465294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Rare Case of Pleural Epithelioid Mesothelioma With a Prominent Myxoid Stroma Reported With Morphology, Fluorescent In Situ Hybridization, and Ultrastructural Findings.
    Sonobe H; Omote R; Habara T; Washio K; Yamazoe N; Matsumoto S; Nabeshima K; Toda H
    Cureus; 2024 Jun; 16(6):e62212. PubMed ID: 39006698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesothelioma in situ with regressive malignant pleural effusion and an unexpected evolution: A case report.
    Almeida GC; Santos UP; Parente YDM; Colares PFB; Mizutani RF; Bernardi FDC; Terra RM; Terra-Filho M
    Am J Ind Med; 2022 Jul; 65(7):620-623. PubMed ID: 35524457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
    Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
    Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytological Assessment of Desmoplastic Malignant Pleural Mesothelioma in an Autopsy Case.
    Kawamoto Y; Kure S; Katayama H; Kawahara K; Teduka K; Kunugi S; Onda M; Motoda N; Ohashi R
    J Nippon Med Sch; 2023 Feb; 89(6):616-622. PubMed ID: 34840219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma.
    Pillappa R; Maleszewski JJ; Sukov WR; Bedroske PP; Greipp PT; Boland JM; Yi ES; Peikert T; Aubry MC; Roden AC
    Am J Surg Pathol; 2018 Feb; 42(2):256-263. PubMed ID: 29076876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gelatinous Pleural Effusion: A Diagnostic Challenge for Pleural Mesothelioma in an 80-Year-Old Man.
    Ibnian AM; Khan OU; Chan R; Bangalore Lakshminarayana U; Kiran F; Abed S; Abbas R; Amir A; Al-Kofahi NK
    Am J Case Rep; 2023 Oct; 24():e941263. PubMed ID: 37793939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma.
    Kinoshita Y; Hida T; Hamasaki M; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Hiroshima K; Oda Y; Nabeshima K
    Cancer Cytopathol; 2018 Jan; 126(1):54-63. PubMed ID: 29053210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence in situ hybridization detection of chromosome 22 monosomy in pleural effusion cytology for the diagnosis of mesothelioma.
    Kinoshita Y; Hamasaki M; Matsumoto S; Yoshimura M; Sato A; Tsujimura T; Kamei T; Kawahara K; Iwasaki A; Nabeshima K
    Cancer Cytopathol; 2021 Jul; 129(7):526-536. PubMed ID: 33493384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytological features of effusions with mesothelioma in situ: A report of 9 cases.
    Michael CW; Bedrossian CCWM; Sadri N; Klebe S
    Diagn Cytopathol; 2023 Jun; 51(6):374-388. PubMed ID: 36942732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual case of chylothorax.
    Benninger LA; Ross JA; Leon ME; Reddy R
    Respir Med Case Rep; 2018; 25():318-322. PubMed ID: 30402386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An autopsy case of desmoplastic malignant mesothelioma].
    Nakagomi T; Kitada O; Nakamura H; Miyata S; Aragane K; Kodama T; Kuribayashi K; Jin S; Takenaka N; Nagasawa N; Sugita M
    Nihon Kokyuki Gakkai Zasshi; 2002 Aug; 40(8):697-702. PubMed ID: 12428402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue.
    Hida T; Matsumoto S; Hamasaki M; Kawahara K; Tsujimura T; Hiroshima K; Kamei T; Taguchi K; Iwasaki A; Oda Y; Honda H; Nabeshima K
    Cancer Sci; 2015 Nov; 106(11):1635-41. PubMed ID: 26291840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens.
    Hwang HC; Sheffield BS; Rodriguez S; Thompson K; Tse CH; Gown AM; Churg A
    Am J Surg Pathol; 2016 Jan; 40(1):120-6. PubMed ID: 26448191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAP1 Immunostain and CDKN2A (p16) FISH Analysis: Clinical Applicability for the Diagnosis of Malignant Mesothelioma in Effusions.
    Walts AE; Hiroshima K; McGregor SM; Wu D; Husain AN; Marchevsky AM
    Diagn Cytopathol; 2016 Jul; 44(7):599-606. PubMed ID: 27121152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant mesothelioma in situ.
    Churg A; Hwang H; Tan L; Qing G; Taher A; Tong A; Bilawich AM; Dacic S
    Histopathology; 2018 May; 72(6):1033-1038. PubMed ID: 29350783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.